UAE – AbbVie’s TEPKINLY (epcoritamab) has been given conditional regulatory approval by the Ministry of Health and Prevention (MoHAP) to treat aggressive types of Diffuse Large B-Cell Lymphoma (DLBCL). TEPKINLY…
Read MoreAbbVie’s oncology drug epcoritamab receives conditional regulatory approval in the UAE
